Please login to the form below

Not currently logged in
Email:
Password:

Social marketing toolbox launched

A social marketing planning guide and toolbox, has been launched by the DH-established National Social Marketing Centre

The National Social Marketing Centre (NSMC) has launched a social marketing planning guide and toolbox, aimed primarily at those working at the consumer end of health promotion.

The NSMC was set up by the Department of Health (DH) to assist in delivering its National Social Marketing Strategy for Health.

The planning guide and toolbox are intended to ensure social marketing practitioners have the tools and confidence required to implement an effective social marketing initiative. 

The web-based tools guide the user through all aspects of a campaign with material broken down into six steps:

  • Getting started
  • Scoping
  • Development
  • Implementation
  • Evaluation
  • Follow up

At each stage the user can download a variety of toolkits containing checklists and other relevant resources.

 NSMC director, John Bromley, said: "The NSMC has the expertise to offer strategic advice to government and other national organisations and to establish and maintain standards in social marketing. While until now, our work has focused mainly on health initiatives, we know that social marketing is an essential component of many other areas where behavioural change is desirable or necessary, be it transport, the environment or energy efficiency."

The NSMC has commissioned the British Standards Institute (BSI) to identify the most appropriate way to establish and maintain a set of standards for social marketing.

The toolkit can be accessed at: www.socialmarketing-toolbox.com (registration required).

11th March 2010

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...